176 related articles for article (PubMed ID: 34439175)
1. MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3.
Souri Z; Wierenga APA; Kiliç E; Brosens E; Böhringer S; Kroes WGM; Verdijk RM; van der Velden PA; Luyten GPM; Jager MJ
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439175
[TBL] [Abstract][Full Text] [Related]
2.
Souri Z; Wierenga APA; Kroes WGM; van der Velden PA; Verdijk RM; Eikmans M; Luyten GPM; Jager MJ
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503258
[TBL] [Abstract][Full Text] [Related]
3. Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma.
Souri Z; Wierenga APA; van Weeghel C; van der Velden PA; Kroes WGM; Luyten GPM; van der Burg SH; Jochemsen AG; Jager MJ
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382450
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.
van Essen TH; van Pelt SI; Bronkhorst IH; Versluis M; Némati F; Laurent C; Luyten GP; van Hall T; van den Elsen PJ; van der Velden PA; Decaudin D; Jager MJ
PLoS One; 2016; 11(10):e0164292. PubMed ID: 27764126
[TBL] [Abstract][Full Text] [Related]
5. Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma.
Souri Z; Jochemsen AG; Wierenga APA; Kroes WGM; Verdijk RM; van der Velden PA; Luyten GPM; Jager MJ
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439300
[TBL] [Abstract][Full Text] [Related]
6. Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
Venkatesan N; Kanwar J; Deepa PR; Khetan V; Crowley TM; Raguraman R; Sugneswari G; Rishi P; Natarajan V; Biswas J; Krishnakumar S
PLoS One; 2016; 11(1):e0146128. PubMed ID: 26812476
[TBL] [Abstract][Full Text] [Related]
7. Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution.
Brouwer NJ; Gezgin G; Wierenga APA; Bronkhorst IHG; Marinkovic M; Luyten GPM; Versluis M; Kroes WGM; van der Velden PA; Verdijk RM; Jager MJ
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31337000
[TBL] [Abstract][Full Text] [Related]
8. HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.
Souri Z; Wierenga APA; Mulder A; Jochemsen AG; Jager MJ
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31394860
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics.
Wierenga APA; Gezgin G; van Beelen E; Eikmans M; Spruyt-Gerritse M; Brouwer NJ; Versluis M; Verdijk RM; van Duinen SG; Marinkovic M; Luyten GPM; Jager MJ
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31426578
[TBL] [Abstract][Full Text] [Related]
10. BAP1 Immunoreactivity Correlates with Gene Expression Class in Uveal Melanoma.
See TR; Stålhammar G; Phillips S; Grossniklaus HE
Ocul Oncol Pathol; 2020 Mar; 6(2):129-137. PubMed ID: 32258021
[TBL] [Abstract][Full Text] [Related]
11. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
Mergener S; Siveke JT; Peña-Llopis S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
13. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
[TBL] [Abstract][Full Text] [Related]
14. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
[TBL] [Abstract][Full Text] [Related]
15. Ischemia Is Related to Tumour Genetics in Uveal Melanoma.
Brouwer NJ; Wierenga APA; Gezgin G; Marinkovic M; Luyten GPM; Kroes WGM; Versluis M; van der Velden PA; Verdijk RM; Jager MJ
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31323773
[TBL] [Abstract][Full Text] [Related]
16. BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers.
Ida CM; Pulido J; Greipp PT; Garcia JJ; Olsen TW; Dalvin L; Salomão DR
Ocul Oncol Pathol; 2022 Feb; 8(1):22-29. PubMed ID: 35356602
[TBL] [Abstract][Full Text] [Related]
17. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
18. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.
Farquhar N; Thornton S; Coupland SE; Coulson JM; Sacco JJ; Krishna Y; Heimann H; Taktak A; Cebulla CM; Abdel-Rahman MH; Kalirai H
J Pathol Clin Res; 2018 Jan; 4(1):26-38. PubMed ID: 29416875
[TBL] [Abstract][Full Text] [Related]
19. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
20. Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?
van Weeghel C; Wierenga APA; Versluis M; van Hall T; van der Velden PA; Kroes WGM; Pfeffer U; Luyten GPM; Jager MJ
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31394807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
